TABLE 3.

Extragenital GC and CT Test Visit Positivity Associated With Concurrent Negative Urethral Test Visits—STD Surveillance Network, 2015–2019

Jurisdiction	Test Visits With Negative Urethral GC Test and Extragenital GC		Test Visits With Negative Urethral CT Test and Extragenital CT
	All Test Visits	Test Visits With Positive Extragenital GC Test	All Test Visits	Test Visits With Positive Extragenital CT Test
	N	n (%)	N	n(%)
Total	17,853	13,341	12,263	10,856
Weighted total positivity (95% CI)		74.8 (71.1–78.5)		88.6 (87.0–90.2)
Unweighted positivity by jurisdiction
Baltimore, MD	347	230 (66.3)	204	181 (88.7)
Los Angeles County, CA*,†	1085	818 (75.4)	699	623 (89.1)
Miami, FL*,‡	257	213 (82.9)	293	272 (92.8)
Boston, MA	47	36 (76.6)	93	82 (88.2)
Multnomah County, OR	1064	836 (78.6)	821	718 (87.5)
Minneapolis, MN	1898	1547 (81.5)	1685	1510 (89.6)
New York City, NY	7173	5194(72.4)	4355	3798 (87.2)
Philadelphia. PA	1796	1314 (73.2)	951	848 (89.2)
San Francisco, CA	3137	2516 (80.2)	2523	2302(91.2)
Seattle, WA	1049	637 (60.7)	639	522 (81.7)

^*Participating clinics did not perform pharyngeal CT testing.

^†Data obtained in 2019 from participating clinics were not available for this analysis.

^‡Participating clinics did not perform pharyngeal GC.